Views & Analysis

Views & Analysis
Coronavirus pharma news roundup

Coronavirus pharma news roundup – 22/05/20

Trials for vaccines and drugs to fight coronavirus dominated the news this week as funding ramped up and several pharma firms announced positive signs from their studies.

Views & Analysis
Innovating in inflammation and immunology

Innovating in inflammation and immunology

For World Inflammatory Bowel Disease day we spoke to Pfizer’s Matt Shaulis, president of international developed markets for inflammation and immunology, to hear how the company hopes to ha

Views & Analysis
Coronavirus pharma news roundup 15/5/20

Coronavirus pharma news roundup 15/5/20

This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.

Views & Analysis
Surviving as a rare disease biotech during COVID-19

Surviving as a rare disease biotech during COVID-19

With trial delays, social distancing, and falls in charitable funding, the coronavirus pandemic presents some serious challenges for nonprofit orphan disease biotechs like Cure Rare Disease